RHI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Robert Half Inc (RHI) does not present a strong buy opportunity for a beginner, long-term investor at this time. The stock is underperforming significantly, facing headwinds from a cooling labor market, slower corporate hiring, and concerns about AI disruption in the white-collar temp staffing industry. Additionally, financial performance has been weak, with declining revenue, net income, and EPS. The options data and technical indicators suggest a neutral to bearish sentiment, and there are no strong positive catalysts to justify a buy decision.
The MACD is slightly positive but contracting, RSI is neutral at 52.852, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 24.653, with resistance at 25.826 and support at 23.481. Overall, the technical indicators suggest a lack of strong momentum in either direction.
The stock's low exposure to AI disruption could be a relative advantage compared to peers in the information services sector. Some analysts have raised price targets recently, reflecting slight optimism.
Martin Capital's complete exit from its position in RHI reflects a lack of confidence in the company's future. The cooling labor market and slower corporate hiring are significant headwinds. The company's financial performance has been deteriorating, and the stock has underperformed the S&P 500 by a wide margin over the past year.
In Q4 2025, revenue dropped by -5.79% YoY to $1.302 billion, net income declined by -41.51% YoY to $31.76 million, and EPS fell by -39.62% YoY to $0.32. Gross margin also contracted by -3.02% YoY to 37.59%. These figures indicate significant financial challenges.
Analyst sentiment is mixed to negative. Barclays recently lowered its price target to $25, citing low AI disruption exposure but maintaining an Equal Weight rating. Goldman Sachs raised its target to $27 but kept a Sell rating, citing long-term headwinds. Truist and Baird have higher price targets ($40 and $50, respectively) but acknowledge challenges such as higher SG&A costs and AI-related risks.
